A leader in the success game: Allogene Therapeutics Inc (ALLO) Stock

JMP Securities raised the price target for the Allogene Therapeutics Inc (NASDAQ:ALLO) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 05, 2024, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $7. In their research brief published […]

It is likely that Allogene Therapeutics Inc (ALLO) Stock will grow up

JMP Securities raised the price target for the Allogene Therapeutics Inc (NASDAQ:ALLO) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 05, 2024, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $7. In their research brief published […]

The Allogene Therapeutics Inc (ALLO) Stock expansion path ahead

JMP Securities raised the price target for the Allogene Therapeutics Inc (NASDAQ:ALLO) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 05, 2024, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $7. In their research brief published […]

Allogene Therapeutics Inc (NASDAQ:ALLO) Stock downgraded by JMP Securities

JMP Securities raised the price target for the Allogene Therapeutics Inc (NASDAQ:ALLO) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 05, 2024, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $7. In their research brief published […]

Hold on to your shares: Allogene Therapeutics Inc (ALLO) Stock

JMP Securities raised the price target for the Allogene Therapeutics Inc (NASDAQ:ALLO) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 05, 2024, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $7. In their research brief published […]

Is Allogene Therapeutics Inc (ALLO) Stock A Better Investment Than Its Rivals?

JMP Securities raised the price target for the Allogene Therapeutics Inc (NASDAQ:ALLO) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 05, 2024, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $7. In their research brief published […]

The high-quality value of Allogene Therapeutics Inc (ALLO) Stock is hidden beneath the surface

JMP Securities raised the price target for the Allogene Therapeutics Inc (NASDAQ:ALLO) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 05, 2024, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to […]

Why Allogene Therapeutics Inc (NASDAQ:ALLO) Stock went down -39.17% in Last Year?

JMP Securities raised the price target for the Allogene Therapeutics Inc (NASDAQ:ALLO) stock from “a Mkt outperform” to “a Mkt perform”. The rating was released on January 05, 2024, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to […]